Is CardieX Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, CardieX Ltd (CDX.AX) is currently classified as HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is CardieX Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes CardieX Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of CardieX Ltd?

Muslim investors may consider investing in CardieX Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is CardieX Ltd classified as HALAL?

Musaffa determines the Shariah status of CardieX Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for CardieX Ltd updated?

The Shariah compliance status of CardieX Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like CardieX Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of CardieX Ltd?

You can check the latest Shariah compliance status of CardieX Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

CDX.AX Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: July 29, 2025

Report Source: 2025 2nd Quarter Report

CardieX Ltd. Stock Analysis CDX.AX

Australia Health Care Nano Cap Report: Q2, 2025

CardieX Ltd. engages in the provision of designing, manufacturing, and marketing medical devices used in cardiovascular health management. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-11-09. The firm develops and markets noninvasive patient monitoring technologies for assessing cardiovascular health. The company specializes in the development of biomarkers and digital solutions for large-scale cardiovascular health disorders. Its solutions are designed to be deployed at point-of-care for arterial health screening, and as part of a remote patient monitoring regimen to extend care and enhance cardiovascular health outcomes. Its suite of products includes medical and home health devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders all based on the Company’s SphygmoCor vascular biomarker technology. Its products include CONNEQT Pulse, SphygmoCor XCEL, and Oscar 2 Ambulatory Blood Pressure Monitor. CONNEQT Pulse measures both brachial and central blood pressures alongside a suite of vascular biomarkers to provide unparalleled insights into vascular health.

Key Statistics of CardieX Ltd (CDX.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.03AUD0.03

Today's Open

AUD0.03

Volume

360.42K

P/E Ratio (TTM)

52 Week Range

AUD0.03AUD0.16

Market Cap

15.40M

Avg. Volume

72.17K

Dividend Yield

Financial Metrics & Statements of CardieX Ltd (CDX.AX)

FAQ's for CardieX Ltd (CDX.AX)

According to Musaffa’s Shariah screening methodology, CardieX Ltd (CDX.AX) is currently classified as HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.